Julie D Reville, MS CCCSLP | |
2 Church St, Suite 4g, Burlington, VT 05401-4299 | |
(802) 734-0777 | |
Not Available |
Full Name | Julie D Reville |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 2 Church St, Burlington, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033237581 | NPI | - | NPPES |
4149910 | Other | MVP | |
00049731 | Other | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 01038597 (* (Not Available)) | Secondary |
101YM0800X | Counselor - Mental Health | 068-0000747 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Julie D Reville, MS CCCSLP 2 Church St, Suite 4g, Burlington, VT 05401-4299 Ph: (802) 734-0777 | Julie D Reville, MS CCCSLP 2 Church St, Suite 4g, Burlington, VT 05401-4299 Ph: (802) 734-0777 |
News Archive
Bristol-Myers Squibb Company today announced it will split off its holdings in Mead Johnson Nutrition Company. The company expects the split-off to be a tax-advantaged way to further deliver value to Bristol-Myers Squibb shareholders.
Drugmaker GlaxoSmithKline has agreed to plead guilty to fraud charges and pay $3 billion in total - with some money going to nearly every state - for promoting its bestselling antidepressants such as Paxil and Wellbutrin for unapproved uses, failing to report safety data about a top diabetes drug and improperly marketing other drugs.
Mayo Medical School has been awarded a grant from the American Medical Association's Accelerating Change in Medical Education program to develop a curriculum to better prepare students for the fast-changing world of health care. The medical school, with operations at Mayo Clinic campuses in Minnesota, Arizona and Florida, will receive $1 million from the AMA program over five years.
College-age football players who gain weight to add power to their blocks and tackles might also be setting themselves up for diabetes and heart disease later in life, a new study suggests.
Bactiguard has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India. A signing process will take place at the Swedish Ambassador's residency tonight.
› Verified 6 days ago